KR890009380A - 서방성 약학제제 - Google Patents

서방성 약학제제 Download PDF

Info

Publication number
KR890009380A
KR890009380A KR1019880017054A KR880017054A KR890009380A KR 890009380 A KR890009380 A KR 890009380A KR 1019880017054 A KR1019880017054 A KR 1019880017054A KR 880017054 A KR880017054 A KR 880017054A KR 890009380 A KR890009380 A KR 890009380A
Authority
KR
South Korea
Prior art keywords
pharmaceutical dosage
dosage form
form according
active ingredient
coating mixture
Prior art date
Application number
KR1019880017054A
Other languages
English (en)
Other versions
KR960009650B1 (en
Inventor
스티븐스 하워드
샤리오 마리본느
아놀드 프랑소와
루이스 가레스
Original Assignee
에. 뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에. 뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR890009380A publication Critical patent/KR890009380A/ko
Application granted granted Critical
Publication of KR960009650B1 publication Critical patent/KR960009650B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Abstract

내용 없음

Description

서방성 약학제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 유효성분을 함유하며 에틸셀룰로오스와 유드라짓 RS의 혼합물로 피복된 미립자와 구성되는 것을 특징으로 하는 pH에 무관하게 유효성분의 조절된 용해를 허용하는 서방성 약학 투여형태.
  2. 제1항에 있어서, 피복혼합물은 60내지 40중량%의 에틸 셀룰로오스와 40내지 60중량%의 유드라짓 RS로 구성되는 것을 특징으로 하는 약학 투여형태.
  3. 제1항 또는 제2항에 있어서, 피복혼합물은 45중량%의 에틸 셀룰로오스와 55중량%의 유드라짓 RS로 구성되는 것을 특징으로 하는 약학 투여형태.
  4. 제1항 내지 제3항중 어느 하나에 있어서, 피복혼합물은 또한 가소제를 함유하는 것을 특징으로 하는 약학 투여형태.
  5. 제4항에 있어서, 피복 혼합물은 아세틸화 모노글리세리드를 함유하는 것을 특징으로 하는 약학 투여형태.
  6. 제1항 내지 제5항중 어느 하나에 있어서, 미립자는 희석제 및 결합제와 조합하여 유효성분을 함유하는 것을 특징으로 하는 약학 투여형태.
  7. 제6항에 있어서, 희석제를 미소 결정성 셀룰로오스인 것을 특징으로 하는 약학 투여형태.
  8. 제6항 또는 제7항에 있어서, 결합제는 카르복시 메틸셀룰로오스인 것을 특징으로 하는 약학 투여형태.
  9. 제1항 내지 제8항중 어느 한항에 있어서, 유효성분은 딜티아젬 염산염인 것을 특징으로 하는 약학 투여형태.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR88017054A 1987-12-21 1988-12-20 Sustained release pharmaceutical composition of diltiazem KR960009650B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8717855 1987-12-21
FR8717855A FR2624732B1 (fr) 1987-12-21 1987-12-21 Formulation pharmaceutique a liberation prolongee

Publications (2)

Publication Number Publication Date
KR890009380A true KR890009380A (ko) 1989-08-01
KR960009650B1 KR960009650B1 (en) 1996-07-23

Family

ID=9358116

Family Applications (1)

Application Number Title Priority Date Filing Date
KR88017054A KR960009650B1 (en) 1987-12-21 1988-12-20 Sustained release pharmaceutical composition of diltiazem

Country Status (23)

Country Link
US (1) US5112621A (ko)
EP (1) EP0322277B1 (ko)
JP (1) JPH082782B2 (ko)
KR (1) KR960009650B1 (ko)
AR (1) AR243378A1 (ko)
AT (1) ATE71837T1 (ko)
AU (1) AU609916B2 (ko)
CA (1) CA1332567C (ko)
DE (1) DE3868037D1 (ko)
DK (1) DK172370B1 (ko)
ES (1) ES2051881T3 (ko)
FI (1) FI97445C (ko)
FR (1) FR2624732B1 (ko)
GR (1) GR3003826T3 (ko)
HU (1) HU199685B (ko)
IE (1) IE60313B1 (ko)
IL (1) IL88736A (ko)
IT (1) IT8723196A0 (ko)
MX (1) MX169322B (ko)
NO (1) NO179357C (ko)
NZ (1) NZ227412A (ko)
PT (1) PT89276B (ko)
ZA (1) ZA889495B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100407519B1 (ko) * 2001-08-31 2003-12-18 부광약품 주식회사 건조황산제일철과 방출조절제로서 엘-글루타민을 함유하는서방성 정제 및 그의 제조방법

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
WO1993024109A1 (en) * 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
US5376384A (en) * 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
JP3264722B2 (ja) * 1993-02-25 2002-03-11 第一製薬株式会社 カプセル製剤
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (fr) 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
AU8293498A (en) 1997-07-02 1999-01-25 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
TR200002771T2 (tr) * 1998-03-26 2001-02-21 Fujisawa Pharmaceutical Co.,Ltd. Devamlı salımı olan preparatlar
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
US6663896B1 (en) 2001-08-01 2003-12-16 Alvin S. Blum Delayed release aspirin for vascular obstruction prophylaxis
KR100446818B1 (ko) * 2001-11-06 2004-09-01 김재윤 질산 이소소르비드 서방성 펠렛 제형
RU2376988C2 (ru) 2003-10-29 2009-12-27 Уайт Фармацевтические композиции замедленного высвобождения, содержащие аплиндор и его производные
EP1730516A1 (en) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Method and device for evaluation of pharmaceutical compositions
KR100775957B1 (ko) * 2006-02-07 2007-11-13 경상대학교산학협력단 애기장대 유래의 개화시기를 조절 단백질 ｃｏ의 돌연변이단백질, 상기 단백질을 이용한 식물의 개화시기 조절전사인자의 분리방법 및 식물의 개화시기 조절방법
CN100442981C (zh) * 2006-11-09 2008-12-17 广东省昆虫研究所 一种德国小蠊毒饵
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
US20100119612A1 (en) * 2007-04-17 2010-05-13 Bend Research, Inc Nanoparticles comprising non-crystalline drug
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
US8974827B2 (en) * 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2550863A1 (de) * 2011-07-27 2013-01-30 Bayer Intellectual Property GmbH Aktivstoffhaltige Partikel auf Polyacrylat-Basis
SI2970101T1 (sl) 2013-03-14 2018-09-28 Alkermes Pharma Ireland Limited Prozdravila fumaratov in njihova uporaba pri zdravljenju različnih bolezni
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
KR101639163B1 (ko) * 2015-07-08 2016-07-22 울산대학교 산학협력단 저전송 영상 정보 및 센싱 정보 송수신 장치 및 이의 동작 방법
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4533674A (en) * 1983-10-24 1985-08-06 Basf Wyandotte Corporation Process for preparing a sugar and starch free spray-dried vitamin C powder containing 90 percent ascorbic acid
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
JPS625915A (ja) * 1985-07-03 1987-01-12 Nippon Iyakuhin Kogyo Kk 塩酸ジルチアゼム徐放性製剤及びその製法
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100407519B1 (ko) * 2001-08-31 2003-12-18 부광약품 주식회사 건조황산제일철과 방출조절제로서 엘-글루타민을 함유하는서방성 정제 및 그의 제조방법

Also Published As

Publication number Publication date
NO885641D0 (no) 1988-12-20
JPH082782B2 (ja) 1996-01-17
IL88736A (en) 1992-11-15
FI885884A0 (fi) 1988-12-20
NO179357C (no) 1996-09-25
DE3868037D1 (de) 1992-03-05
EP0322277B1 (fr) 1992-01-22
FI97445C (fi) 1996-12-27
PT89276B (pt) 1993-12-31
IE60313B1 (en) 1994-06-29
DK708088A (da) 1989-06-29
MX169322B (es) 1993-06-29
AU2707788A (en) 1989-06-22
PT89276A (pt) 1989-12-29
US5112621A (en) 1992-05-12
NO885641L (no) 1989-06-22
NO179357B (no) 1996-06-17
EP0322277A1 (fr) 1989-06-28
IL88736A0 (en) 1989-07-31
JPH02202A (ja) 1990-01-05
CA1332567C (en) 1994-10-18
DK708088D0 (da) 1988-12-20
ES2051881T3 (es) 1994-07-01
ATE71837T1 (de) 1992-02-15
FR2624732B1 (fr) 1991-02-15
IE883810L (en) 1989-06-21
FI885884A (fi) 1989-06-22
AU609916B2 (en) 1991-05-09
IT8723196A0 (it) 1987-12-23
GR3003826T3 (ko) 1993-03-16
HUT49290A (en) 1989-09-28
NZ227412A (en) 1989-12-21
DK172370B1 (da) 1998-04-27
KR960009650B1 (en) 1996-07-23
ZA889495B (en) 1989-09-27
AR243378A1 (es) 1993-08-31
FI97445B (fi) 1996-09-13
HU199685B (en) 1990-03-28
FR2624732A1 (fr) 1989-06-23

Similar Documents

Publication Publication Date Title
KR890009380A (ko) 서방성 약학제제
KR930003905A (ko) 약학적 결합 제제
KR900007397A (ko) 서방성 제제
KR910004180A (ko) 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
DK0431877T3 (da) Cimetidinholdige farmaceutiske midler
KR870002832A (ko) 제약 조성물
ATE228825T1 (de) Orale dosierungsformen mit pulverschicht
NO992263D0 (no) Belagte partikler, fremgangsmÕte for fremstilling og anvendelse av slike
SE9102072D0 (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
NL300281I2 (nl) Exenatide, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
ATE44460T1 (de) Arzneimittelueberzug.
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
KR890009376A (ko) 분무 건조된 이부프로펜
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
MX9707585A (es) Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
SE9301667D0 (sv) New use
KR950031052A (ko) 알푸조신 히드로클로라이드의 서방성 투약형태
KR890007721A (ko) 맛 은폐를 위한 수단을 포함하는 저작가능한 의약 정제
KR890003292A (ko) 안정화된 사료 첨가제 및 이의 제조방법
HUP9904129A2 (hu) Hatóanyagként diltiazemet tartalmazó nyújtott hatóanyag-leadású mikroszemcsék
TR199801126T2 (xx) Tolfenamik asit veya bunun farmas�tik a��dan kabul edilebilir bir tuzunu i�eren h�zl� tahliye edici tablet.
DK1105099T3 (da) Sammensætning af fiskegelatine til brug som ingrediens i tabletter
RU93043304A (ru) Кормовые или медикаментозные композиции для жвачных животных и способ их получения
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
KR910016321A (ko) 작용시간이 긴 입상 약제학적 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100719

Year of fee payment: 15

EXPY Expiration of term